In contrast, CCL22, abundantly expressed in many types of cancer and instrumental for intratumoral recruitment of Treg (Anz et al, 2015), was down-regulated by Tα1 in DC and at the tumor site. This evidence concerns the gene CCL22 and neoplasm.